144 related articles for article (PubMed ID: 10581424)
1. Development and evaluation of a multiple-unit oral sustained release dosage form for S(+)-ibuprofen: preparation and release kinetics.
Cox PJ; Khan KA; Munday DL; Sujja-areevath J
Int J Pharm; 1999 Dec; 193(1):73-84. PubMed ID: 10581424
[TBL] [Abstract][Full Text] [Related]
2. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
Sankalia JM; Sankalia MG; Mashru RC
J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
[TBL] [Abstract][Full Text] [Related]
3. Guar gum, xanthan gum, and HPMC can define release mechanisms and sustain release of propranolol hydrochloride.
Mughal MA; Iqbal Z; Neau SH
AAPS PharmSciTech; 2011 Mar; 12(1):77-87. PubMed ID: 21174179
[TBL] [Abstract][Full Text] [Related]
4. Modulation of active pharmaceutical material release from a novel 'tablet in capsule system' containing an effervescent blend.
Gohel MC; Sumitra G M
J Control Release; 2002 Feb; 79(1-3):157-64. PubMed ID: 11853927
[TBL] [Abstract][Full Text] [Related]
5. Drug release kinetics from tablet matrices based upon ethylcellulose ether-derivatives: a comparison between different formulations.
Khan GM; Meidan VM
Drug Dev Ind Pharm; 2007 Jun; 33(6):627-39. PubMed ID: 17613027
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability of ibuprofen from hot-melt extruded mini-matrices.
De Brabander C; Vervaet C; Van Bortel L; Remon JP
Int J Pharm; 2004 Mar; 271(1-2):77-84. PubMed ID: 15129975
[TBL] [Abstract][Full Text] [Related]
7. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
Cao QR; Choi YW; Cui JH; Lee BJ
J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
[TBL] [Abstract][Full Text] [Related]
8. Studies in release behavior of diltiazem HCl from matrix tablets containing (hydroxypropyl)methyl cellulose and xanthan gum.
Gohel MC; Amin AF; Patel KV; Panchal MK
Boll Chim Farm; 2002; 141(1):21-8. PubMed ID: 12064053
[TBL] [Abstract][Full Text] [Related]
9. Controlled release of dual drug-loaded hydroxypropyl methylcellulose matrix tablet using drug-containing polymeric coatings.
Lee BJ; Ryu SG; Cui JH
Int J Pharm; 1999 Oct; 188(1):71-80. PubMed ID: 10528084
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of selected polysaccharide excipients in buccoadhesive tablets for sustained release of nicotine.
Park CR; Munday DL
Drug Dev Ind Pharm; 2004 Jul; 30(6):609-17. PubMed ID: 15285334
[TBL] [Abstract][Full Text] [Related]
11. Xanthan gum to tailor drug release of sustained-release ethylcellulose mini-matrices prepared via hot-melt extrusion: in vitro and in vivo evaluation.
Verhoeven E; Vervaet C; Remon JP
Eur J Pharm Biopharm; 2006 Jul; 63(3):320-30. PubMed ID: 16517135
[TBL] [Abstract][Full Text] [Related]
12. The performance of HPMC matrix tablets using various agglomeration manufacturing processes.
Košir D; Vrečer F
Drug Dev Ind Pharm; 2017 Feb; 43(2):329-337. PubMed ID: 27739880
[TBL] [Abstract][Full Text] [Related]
13. A novel approach to sustained pseudoephedrine release: differentially coated mini-tablets in HPMC capsules.
Ishida M; Abe K; Hashizume M; Kawamura M
Int J Pharm; 2008 Jul; 359(1-2):46-52. PubMed ID: 18467046
[TBL] [Abstract][Full Text] [Related]
14. [Effect of the sustained release excipients on the release rate of ginsenoside Rg1 and ginsenoside Rb1 in sustained-release tablet of Panax notoginsenosides].
Wu Q; Chen XC; Du SY
Zhongguo Zhong Yao Za Zhi; 2004 Oct; 29(10):944-7. PubMed ID: 15631077
[TBL] [Abstract][Full Text] [Related]
15. Application of similarity factor in development of controlled-release diltiazem tablet.
Peh KK; Wong CF
Drug Dev Ind Pharm; 2000 Jul; 26(7):723-30. PubMed ID: 10872090
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of the dissolution characteristics of capsule and tablet dosage forms of melt granulations of paracetamol--diluent effects.
Uhumwangho MU; Okor RS
Acta Pol Pharm; 2007; 64(1):73-9. PubMed ID: 17665854
[TBL] [Abstract][Full Text] [Related]
17. High molecular weight polyethylene oxides (PEOs) as an alternative to HPMC in controlled release dosage forms.
Maggi L; Bruni R; Conte U
Int J Pharm; 2000 Feb; 195(1-2):229-38. PubMed ID: 10675700
[TBL] [Abstract][Full Text] [Related]
18. [Release of diltiazem chloride and ibuprofen from hydrophilic matrix tablets].
Vostalová L; Rabisková M; Medvecká G
Ceska Slov Farm; 2003 Nov; 52(6):295-8. PubMed ID: 14661369
[TBL] [Abstract][Full Text] [Related]
19. Erosion characteristics of an erodible tablet incorporated in a time-delayed capsule device.
McConville JT; Ross AC; Florence AJ; Stevens HN
Drug Dev Ind Pharm; 2005 Jan; 31(1):79-89. PubMed ID: 15704859
[TBL] [Abstract][Full Text] [Related]
20. Modified conventional hard gelatin capsules as fast disintegrating dosage form in the oral cavity.
Ciper M; Bodmeier R
Eur J Pharm Biopharm; 2006 Feb; 62(2):178-84. PubMed ID: 16260126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
